Skip to main content
. 2019 Jan 7;51(1):3. doi: 10.1038/s12276-018-0190-2

Fig. 1. A strategy for developing immunocompatible stem cells using the CRISPR/Cas9 system.

Fig. 1

a HLA allelic type of iPSCs used for immunocompatible cell development. b gRNA-targeted gene locus and sequence for HLA-B engineering. HLA-B.g2 (gRNA) was designed to target an exon of the HLA-B gene. c The vector map of the HLA-B.g2 plasmid. d Predicted region of the HLA-B protein deleted by the CRISPR/Cas9 system